Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster presentation featuring data for the company’s NeXT ...

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360tm -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial ...

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights ...

These were otherwise healthy school-age children who didn’t have to die.” We speak to the world-renowned pediatrician, ...

The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies for rare and common diseases. With momentum building from ...

Companion Diagnostics MarketThe global market for companion diagnostics is set for exponential growth, projected to expand from USD 5,700.5 million in 2024 to USD 11,682.8 million by 2035, registering ...

The World's First De-extinct Dire Wolves - In a secure 2,000+ acre preserve, three white-furred pups are making history with ...

Trans-species infection and transmission of viruses, exemplified by the emergence of influenza and COVID-19 pandemics, present significant global health ...